PulmCCM

Share this post
Ciclesonide tests its "me too" claim vs Advair for asthma
www.pulmccm.org

Ciclesonide tests its "me too" claim vs Advair for asthma

Feb 16, 2011
Share this post
Ciclesonide tests its "me too" claim vs Advair for asthma
www.pulmccm.org

Ciclesonide, a new inhaled corticosteroid that seems to cause thrush less often than others, reached for equivalency with salmeterol/fluticasone in mild persistent asthma. Ciclesonide was better than placebo in controlling asthma but Advair users had a longer time to first asthma exacerbation. CHEST 2011;139: online supplement.

A Cochrane review on ciclesonide could not establish its equivalence with other ICS at higher doses with certainty, but suggested it's roughly equi-efficacious to fluticasone and other ICS.

Share this post
Ciclesonide tests its "me too" claim vs Advair for asthma
www.pulmccm.org
Comments
TopNew

No posts

Ready for more?

© 2023 PulmCCM
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing